MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• The MNK-eIF4E axis, involving MNK1/2 kinases and eIF4E proteins, is crucial for oncogenic mRNA translation and cancer progression.
• Understanding this axis in specific lymphoma subtypes like diffuse large B-cell lymphoma (DLBCL) is essential for targeted therapies.

Purpose of the Study:

• To investigate the role and regulation of the MNK-eIF4E axis in germinal center B-cell (GCB) and activated B-cell (ABC) subtypes of DLBCL.
• To elucidate the functional interplay between MNK1, MNK2, eIF4E1, and eIF4E3 in DLBCL pathogenesis.

Main Methods:

• Differential expression analysis of MNK1 and MNK2 in GCB and ABC DLBCL subtypes.
• Assessment of MNK inhibition effects on eIF4E1 phosphorylation, eIF4E3 expression, and total eIF4E1 protein levels.
• Analysis of eIF4E1 mRNA polysomal loading and translation initiation using translatome profiling.

Main Results:

• MNK1 and MNK2 exhibit distinct distributions in GCB and ABC DLBCL subtypes but functionally complement each other for cell survival.
• MNK inhibition abrogates eIF4E1 phosphorylation, increases eIF4E3 expression, and reduces total eIF4E1 protein by affecting polysomal loading.
• Enhanced eIF4E3 expression modulates eIF4E1 translation and reveals a novel role for eIF4E3 in translation initiation.

Conclusions:

• The MNK-eIF4E axis plays a significant role in DLBCL, with MNKs modulating oncogenic translation through regulation of eIF4E1 and eIF4E3.
• Targeting MNKs could represent a therapeutic strategy for DLBCL by disrupting key translation pathways essential for cancer cell survival.